Skip to main content

Advertisement

SpringerLink
Log in

Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To investigate the effect of aflibercept in a rare case of choroidal neovascularization (CNV) secondary to choroidal osteoma (CO) and refractory to ranibizumab and bevacizumab. A 45-year-old male with CO-related CNV in his left eye received prior two intravitreal 1.25 mg bevacizumab injections and three intravitreal 0.5 mg ranibizumab injections without visual and anatomic improvement. Best-corrected visual acuity assessment, ophthalmic examination, fundus photography, and optical coherence tomography (OCT) were performed. Switching to intravitreal injection of 2.0 mg aflibercept was performed. After three loading doses of intravitreal aflibercept, visual acuity of the left eye improved from 20/50 to 20/32. Resolution of the persistent subfoveal fluid and reduction of retinal hemorrhage were confirmed according to ophthalmoscopy and OCT findings. No serious adverse events were observed. The treatment effect persisted during a 10-month follow-up period. In choroidal osteoma, switching to intravitreal aflibercept injection may be an effective therapeutic option for treatment of CNV refractory to ranibizumab and bevacizumab.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Gass JD, Guerry RK, Jack RL, Harris G (1978) Choroidal osteoma. Arch Ophthalmol 96:428–435

    Article  CAS  PubMed  Google Scholar 

  2. Aylward GW, Chang TS, Pautler SE, Gass JD (1998) A long-term follow-up of choroidal osteoma. Arch Ophthalmol 116:1337–1341

    Article  CAS  PubMed  Google Scholar 

  3. Shields CL, Sun H, Demirci H, Shields JA (2005) Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol 123(12):1658–1666

    Article  PubMed  Google Scholar 

  4. Shields CL, Perez B, Materin MA, Mehta S, Shields JA (2007) Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor. Ophthalmology 114(12):53–58

    Article  Google Scholar 

  5. Ahmadieh H, Vafi N (2007) Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 245:1731–1733

    Article  CAS  PubMed  Google Scholar 

  6. Song WK, Koh HJ, Kwon OW, Byeon SH, Lee SC (2009) Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma. Acta Ophthalmol 87:100–101. doi:10.1111/j.1600-0420.2007.01136.x

    Article  PubMed  Google Scholar 

  7. Pandey N, Guruprasad A (2010) Choroidal osteoma with choroidal neovascular membrane: successful treatment with intravitreal bevacizumab. Clin Ophthalmol 4:1081–1084. doi:10.2147/OPTH.S13730

    Article  PubMed Central  PubMed  Google Scholar 

  8. Song MH, Roh YJ (2009) Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma. Eye (Lond) 23:1745–1746. doi:10.1038/eye.2008.313

    Article  Google Scholar 

  9. Carle MV, Chu TG, Liao D, Boyer DS (2014) Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with choroidal osteoma. Ophthalmic Surg Lasers Imaging Retina 45(2):169–171. doi:10.3928/23258160-20140306-12

    Article  PubMed  Google Scholar 

  10. Mansour AM, Arevalo F, Al Kahtani E et al (2014) Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma. J Ophthalmol 2014:210458. doi:10.1155/2014/210458

    Article  PubMed Central  PubMed  Google Scholar 

  11. Heier JS, Brown DM, Chong V, Korobelnik JF et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(112):2537–2548. doi:10.1016/j.ophtha.2012.09.006

    Article  PubMed  Google Scholar 

  12. Bakall B, Folk JC, Boldt HC et al (2013) Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol 156(1):15–22. doi:10.1016/j.ajo.2013.02.017

    Article  CAS  PubMed  Google Scholar 

  13. Cho H, Shah CP, Weber M, Heier JS (2013) Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab. Br J Ophthalmol 97(8):1032–1035. doi:10.1136/bjophthalmol-2013-303344

    Article  PubMed  Google Scholar 

  14. Kumar N, Marsiglia M, Mrejen S et al (2013) Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Retina 33(8):1605–1612. doi:10.1097/IAE.0b013e31828e8551

    Article  CAS  PubMed  Google Scholar 

  15. Khan MA, DeCroos FC, Storey PP, Shields JA, Garg SJ, Shields CL (2014) Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma. Retina 34(9):1750–1756. doi:10.1097/IAE.0000000000000187

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Ophthalmology Department, Polytechnic University of Marche, Via Conca 71, 60020, Ancona, Italy

    Andrea Saitta, Michele Nicolai, Piergiorgio Neri, Alfonso Giovannini & Cesare Mariotti

  2. Ophthalmology Department, University of Catania, Catania, Italy

    Michele Reibaldi

Authors
  1. Andrea Saitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michele Nicolai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Piergiorgio Neri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michele Reibaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alfonso Giovannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cesare Mariotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Saitta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saitta, A., Nicolai, M., Neri, P. et al. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab. Int Ophthalmol 35, 441–444 (2015). https://doi.org/10.1007/s10792-015-0059-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-015-0059-5

Keywords

Search

Navigation